Evidence map›Paper›PMID 40753274›Full record

ArticleNPJ digital medicine2025

Multi-domain rule-based phenotyping algorithms enable improved GWAS signal.

Abigail Newbury, Ahmed Elhussein, Gamze Gürsoy

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abigail NewburyDepartment of Biomedical Informatics, Columbia University, New York City, NY, USA.
Ahmed ElhusseinDepartment of Biomedical Informatics, Columbia University, New York City, NY, USA.
Gamze GürsoyDepartment of Biomedical Informatics, Columbia University, New York City, NY, USA. gamze.gursoy@columbia.edu.

Funding

Training in Biomedical Informatics at Columbia UniversityT15LM007079 · NLM · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI NOEMIE ELHADAD, GEORGE M HRIPCSAK · 1992 to 2026
$28.9M
Tools to Address the Challenges of Preserving Privacy in Sharing and Analysis of Biomedical DataR35GM147004 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GURSOY, GAMZE · 2022 to 2025
$1.8M
NIGMS NIH HHS R35 GM147004NIGMS NIH HHS R35GM147004NLM NIH HHS T15 LM007079U.S. National Library of Medicine T15LM007079
6 · The paper itself

Abstract

Biobanks are a rich source of data for genome-wide association studies (GWAS). They store clinical data from electronic health records, with data domains such as laboratory measurements, conditions, and self-reported diagnoses. Traditionally, biobank GWAS utilize case-control cohorts built exclusively from conditions. However, because reported conditions are primarily collected for billing purposes, they face data quality issues. Consequently, incorporating additional data domains in cohort construction can improve cohort accuracy and GWAS results. Here, we assess the impact of various rule-based phenotyping algorithms on GWAS outcomes, examining factors such as power, heritability, replicability, functional annotations, and polygenic risk score prediction accuracy across seven diseases in the UK Biobank. We find that high complexity phenotyping algorithms generally improve GWAS outcomes, including increased power, hits within coding and functional genomic regions, and co-localization with expression quantitative trait loci. Our findings suggest that biobank-scale GWAS can benefit from phenotyping algorithms that integrate multiple data domains.

Identifiers

PMID40753274
PMCPMC12318046

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.